<DOC>
	<DOCNO>NCT00680914</DOCNO>
	<brief_summary>The purpose study : To demonstrate immunogenicity term antibody response follow primary vaccination Korean infant pneumococcal conjugate vaccine GSK 1024850A compare Prevenar™ co-administered Haemophilus influenzae type b ( Hib ) vaccine child first 6 month life . To evaluate safety/reactogenicity term solicit unsolicited symptom serious adverse event follow primary vaccination Korean infant pneumococcal conjugate vaccine GSK 1024850A .</brief_summary>
	<brief_title>Primary Vaccination Course Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A Prevenar™ Hiberix™</brief_title>
	<detailed_description>Vaccination course 2 , 4 , 6 month age .</detailed_description>
	<mesh_term>Streptococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Male female subject , include 612 week age time first vaccination . Subjects investigator believe parent ( ) /guardian ( ) comply requirement protocol enrol study . Written sign inform consent obtain parent ( ) /guardian ( ) child/ward . Free know suspected health problem establish medical history clinical examination enter study . Born gestation period 36 42 week inclusive , birth weight least 2.5 kilogram . Use investigational nonregistered product ( drug vaccine ) study vaccine within 30 day precede first dose study vaccine , plan use study period . Concurrently participate another clinical study , time study period , subject expose investigational noninvestigational product ( pharmaceutical product device ) . Chronic administration immunosuppressant immunemodifying drug since birth . Planned administration/administration vaccine allow study protocol study period . Vaccines include Korean routine immunization schedule administer least one week least one month administration study vaccine . Recommended live vaccine include Korean routine immunization schedule give least one month least one month administration study vaccine . A family history congenital hereditary immunodeficiency . Any confirm suspected immunosuppressive immunodeficient condition base medical history physical examination . Administration immunoglobulins and/or blood product since birth plan administration study period ( Hepatitis B immunoglobulins birth allow ) . Previous vaccination Streptococcus pneumoniae and/or Haemophilus influenzae type b . History , intercurrent Streptococcus pneumoniae and/or Haemophilus influenzae type b disease . History allergic disease reaction likely exacerbate component vaccine . History neurological disorder seizure . Major congenital defect serious chronic illness . Acute disease time enrolment . Study entry delayed illness improve .</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>12 Weeks</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Streptococcus pneumoniae</keyword>
	<keyword>pneumococcal conjugate vaccine</keyword>
</DOC>